Answers are grounded in this paper and cite their sources.
Case report shows severe thrombocytopenia causing unusual perimesencephalic hemorrhage and complications in a young woman, indicating caution in similar cases.
A 26-year-old female with severe thrombocytopenia (platelet count <20,000/μL) following combination chemotherapy (cisplatin, paclitaxel, pembrolizumab, and bevacizumab) for cervical cancer presented with new-onset headache and ocular hemorrhage. Perimesencephalic subarachnoid hemorrhage (pmSAH) was identified, which was subsequently complicated by disproportionate cerebral vasospasm and transient oculomotor nerve palsy. This case demonstrates that pmSAH, which is generally considered a benign venous hemorrhage, can follow an unusual course in the setting of profound bleeding diathesis and chemotherapy-induced vascular injury.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: